Drug
Zd6474
Zd6474: highest development phase Phase 2, developed by AstraZeneca, Sanofi. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- AstraZeneca, Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZD6474 NCT00402896 | Phase 2 | Lung Cancer |
| ZD6474 (vandetanib) NCT00358956 | Phase 2 | Thyroid Cancer |
Latest
No recent events.
Follow Zd6474 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.